Shenzhen Toyon Biotechnology limited (Toyon Biotech Ltd) is a Chinese Innovative High-Tech enterprise that focuses on the development of laboratory consumables, novel medical supplies and cutting-edge bio-medical technology. Found in November 2020, Toyon Biotech now has now established research laboratories equipped with state-of-the-art instruments and support facilities, which guaranteed the fulfillment of needs for advanced research activities. Toyon Biotech has a research team comprised of talented scientists, renowned academics and experienced technicians. All members of the research team are well-trained and passionate, ready to devote their brilliant minds to de discovery and development of novel biomedical technologies.

Toyon biotech focused on the research and development of innovative medical devices and supplies. The company’s prime product, optimal surface energy cell culture plate, enables an efficient and reliable method of customized cell sheet engineering. Based on Toyon Biotech’s novel polymer coating technology, optimal surface energy cell culture plate has started a new era of fast and simple cell sheets preparation.

It is our belief that clinical need is the sole motivation of bio-medical technology innovation, and the innovation shall benefit the clinical application. Till this day, Toyon biotech limited has completed multiple critical research project and related patents well soon be granted. Meanwhile, the research team has published more than 10 research articles on SCI-indexed journals, including Stem Cell and Tissue Engineering.

We have established collaborations with universities and research institutes with support of local government agencies, and focused on the stem cell and cell therapy research. The company adheres to the “people-oriented” management philosophy, provides the employees with a relaxed working environment and a platform of opportunities to achieve their personal and career fulfillments, so that employees and the company can grow together. It is Toyon Biotech’s goal to actively lead the next biomedical revolution, and strive to use technology to benefit and serve the well-being of humankind.